Cargando…
Fragment-Based Drug Discovery against Mycobacteria: The Success and Challenges
The emergence of drug-resistant mycobacteria, including Mycobacterium tuberculosis (Mtb) and non-tuberculous mycobacteria (NTM), poses an increasing global threat that urgently demands the development of new potent anti-mycobacterial drugs. One of the approaches toward the identification of new drug...
Autores principales: | Togre, Namdev S., Vargas, Ana M., Bhargavi, Gunapati, Mallakuntla, Mohan Krishna, Tiwari, Sangeeta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500838/ https://www.ncbi.nlm.nih.gov/pubmed/36142582 http://dx.doi.org/10.3390/ijms231810669 |
Ejemplares similares
-
Implications of Fragment-Based Drug Discovery in Tuberculosis and HIV
por: Mallakuntla, Mohan Krishna, et al.
Publicado: (2022) -
Harnessing Immune Evasion Strategy of Lymphatic Filariae: A Therapeutic Approach against Inflammatory and Infective Pathology
por: Bhoj, Priyanka, et al.
Publicado: (2022) -
Protein–protein interaction of Rv0148 with Htdy and its predicted role towards drug resistance in Mycobacterium tuberculosis
por: Bhargavi, Gunapati, et al.
Publicado: (2020) -
Fragment-Based Drug Discovery by NMR. Where Are the Successes and Where can It Be Improved?
por: Mureddu, Luca G., et al.
Publicado: (2022) -
A putative short-chain dehydrogenase Rv0148 of Mycobacterium tuberculosis affects bacterial survival and virulence
por: Bhargavi, Gunapati, et al.
Publicado: (2022)